Science Explorer Back to mapMap
Discussion
Researcher · Incyte (United States) · United States

Douglas James DeMarini

Douglas James DeMarini publishes mostly in Molecular Biology, Oncology and Pathology and Forensic Medicine, on topics such as Melanoma and MAPK Pathways, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.

OpenAlex
World rank
#537,192
of 7,710,434 ranked researchers
Rank in United States
#186,038
of 1,627,098
Works
52
Citations
13k
Citations per work
256.6
h-index
26
i10-index 37Top 20% in Molecular Biology
Douglas James DeMarini

What does Douglas James DeMarini research?

Douglas James DeMarini's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (32%), Agricultural and Biological Sciences (2%).

Life Sciences: 21 works · 40.4% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 38.4% of their workMolecular Biology: 20 works · 38.4% of their workAgricultural and Biological Sciences: 1 works · 2.0% of their workPlant Science: 1 works · 2.0% of their workHealth Sciences: 17 works · 32.5% of their workMedicine: 17 works · 32.5% of their workOncology: 6 works · 11.9% of their workGenetics: 5 works · 9.3% of their workPathology and Forensic Medicine: 5 works · 9.3% of their workHematology: 1 works · 2.0% of their workEverything else: 14 works · 27.1% of their workTHEIR WORKDouglas JamesDeMarini52works
Life Sciences40%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2038.4%
    2. Agricultural and Biological Sciences12.0%
    1. Medicine1732.5%
  3. Everything else1427.1%
  1. 1Molecular Biology38% of their works
  2. 2Oncology12% of their works
  3. 3Pathology and Forensic Medicine9% of their works
  4. 4Genetics9% of their works
  5. 5Hematology2% of their works
  6. 6Plant Science2% of their works

Research topics

Which keywords describe Douglas James DeMarini's research?

The keywords of their largest research topics: Rituximab, Signal Transduction, Melanoma, BRAF gene, Chronic Lymphocytic Leukemia, Genomic Aberrations, MAP Kinase and Classification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab262 topics
  2. Signal Transduction222 topics
  3. Melanoma212 topics
  4. BRAF gene141 topic
  5. Chronic Lymphocytic Leukemia141 topic
  6. Genomic Aberrations141 topic
  7. MAP Kinase141 topic
  8. Classification121 topic
  9. Lymphoma121 topic
  10. Genomics81 topic
  11. Yeast81 topic
  12. Dermoscopy71 topic
  13. Ribosome71 topic
  14. Skin Cancer71 topic
  15. Translation71 topic
  16. Signaling61 topic
  17. mTOR61 topic
  18. Alternative Splicing51 topic
  19. RNA-Binding Proteins51 topic

Where does Douglas James DeMarini work?

Douglas James DeMarini's main affiliation in the publication record is Incyte (United States), United States.

How many publications and citations does Douglas James DeMarini have?

OpenAlex counts 52 works and 13,345 citations for Douglas James DeMarini, an h-index of 26, ranking #537,192 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Douglas James DeMarini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.